Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 CHOP followed by Zevalin in untreated elderly diffuse large B-cell lymphoma
2004-002273-24Phase 2Completed
- Sponsor
- Sant'Orsola-Malpighi University Hospital
- Start
- Apr 2006
- Modality
- Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ibritumomab tiuxetan in diffuse large B-cell lymphoma (DLBCL), sponsored by Sant'Orsola-Malpighi University Hospital. Started Apr 2006; status: completed.
02
Drugs
ibritumomab tiuxetan
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on 2004-002273-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002273-24.